Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Merck & Co Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MRK
New York
2834
https://www.merck.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Merck & Co Inc
Here's Why Merck (MRK) is a Strong Momentum Stock
- May 3rd, 2024 1:50 pm
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
- May 2nd, 2024 6:53 pm
15 Best Places to Retire in Florida That You’ve Never Heard Of
- May 1st, 2024 10:52 pm
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- May 1st, 2024 11:15 am
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
- Apr 30th, 2024 12:44 pm
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
- Apr 29th, 2024 1:00 pm
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
- Apr 27th, 2024 12:24 pm
Merck (MRK) Q1 2024 Earnings Call Transcript
- Apr 25th, 2024 7:30 pm
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
- Apr 25th, 2024 6:29 pm
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
- Apr 25th, 2024 4:09 pm
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
- Apr 25th, 2024 3:42 pm
20 Fastest Growing Health Tech Companies in the World
- Apr 25th, 2024 3:34 pm
Merck raises 2024 guidance on cancer drug demand
- Apr 25th, 2024 3:23 pm
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
- Apr 25th, 2024 1:13 pm
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
- Apr 25th, 2024 1:00 pm
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
- Apr 25th, 2024 11:04 am
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
- Apr 25th, 2024 10:33 am
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
- Apr 25th, 2024 10:30 am
Merck Announces First-Quarter 2024 Financial Results
- Apr 25th, 2024 10:30 am
Alphabet, Microsoft, Southwest earnings: What to watch
- Apr 24th, 2024 9:50 pm
Scroll